BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37458005)

  • 41. FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma.
    Giatromanolaki A; Banham AH; Harris AL; Koukourakis MI
    Exp Lung Res; 2019; 45(3-4):76-83. PubMed ID: 31134811
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic impact of FOXP3 expression in triple-negative breast cancer.
    Lee S; Cho EY; Park YH; Ahn JS; Im YH
    Acta Oncol; 2013 Jan; 52(1):73-81. PubMed ID: 23075422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological significance of the immunologic signature (PDL1, FOXP3+ Tregs, TILs) in early stage triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Abdelrahman AE; Rashed HE; MostafaToam ; Omar A; Abdelhamid MI; Matar I
    Ann Diagn Pathol; 2021 Apr; 51():151676. PubMed ID: 33360026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
    Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
    Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors.
    de Reuver PR; Mehta S; Gill P; Andrici J; D'Urso L; Clarkson A; Mittal A; Hugh TJ; Samra JS; Gill AJ
    J Am Coll Surg; 2016 Mar; 222(3):281-7. PubMed ID: 26809747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
    Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
    Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis.
    Shang B; Liu Y; Jiang SJ; Liu Y
    Sci Rep; 2015 Oct; 5():15179. PubMed ID: 26462617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
    Hashemi V; Maleki LA; Esmaily M; Masjedi A; Ghalamfarsa G; Namdar A; Yousefi M; Yousefi B; Jadidi-Niaragh F
    Int Immunopharmacol; 2020 Jan; 78():106087. PubMed ID: 31841758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.
    Freier CP; Kuhn C; Endres S; Mayr D; Friese K; Jeschke U; Anz D
    Anticancer Res; 2016 Jun; 36(6):3139-45. PubMed ID: 27272839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironment.
    Tagami M; Kakehashi A; Katsuyama-Yoshikawa A; Misawa N; Sakai A; Wanibuchi H; Azumi A; Honda S
    PLoS One; 2022; 17(3):e0263895. PubMed ID: 35358193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
    Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
    PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer.
    Yamagami W; Susumu N; Tanaka H; Hirasawa A; Banno K; Suzuki N; Tsuda H; Tsukazaki K; Aoki D
    Int J Gynecol Cancer; 2011 Dec; 21(9):1628-34. PubMed ID: 21897268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients.
    Sun S; Fei X; Mao Y; Wang X; Garfield DH; Huang O; Wang J; Yuan F; Sun L; Yu Q; Jin X; Wang J; Shen K
    Cancer Immunol Immunother; 2014 Apr; 63(4):395-406. PubMed ID: 24514954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD45RA
    Ihara F; Sakurai D; Horinaka A; Makita Y; Fujikawa A; Sakurai T; Yamasaki K; Kunii N; Motohashi S; Nakayama T; Okamoto Y
    Cancer Immunol Immunother; 2017 Oct; 66(10):1275-1285. PubMed ID: 28551813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients.
    Chan MS; Wang L; Felizola SJ; Ueno T; Toi M; Loo W; Chow LW; Suzuki T; Sasano H
    Int J Biol Markers; 2012 Dec; 27(4):e295-304. PubMed ID: 23280127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.
    Al-Qahtani D; Anil S; Rajendran R
    J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.